Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 30.13M | $ 0 | 0% |
3/31/2025 | $ 38.12M | $ 0 | 0% |
12/31/2024 | $ 44.2M | $ 0 | 0% |
9/30/2024 | $ 53.8M | $ 0 | 0% |
6/30/2024 | $ 61.89M | $ 0 | 0% |
3/31/2024 | $ 71.37M | $ 0 | 0% |
12/31/2023 | $ 83.94M | $ 0 | 0% |
9/30/2023 | $ 28.34M | $ 0 | 0% |
6/30/2023 | $ 35.44M | $ 0 | 0% |
3/31/2023 | $ 42.67M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for SAB BIOTHERAPEUTICS INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 80K ]
(=) Intang. to Assets [ 0% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.21% |
average | 3.99% |
median | 0.52% |
std | 6.09% |